Search Results - "Wu, Yue‐E"

Refine Results
  1. 1

    Machine Learning: A New Approach for Dose Individualization by Li, Qiu‐Yue, Tang, Bo‐Hao, Wu, YueE, Yao, Bu‐Fan, Zhang, Wei, Zheng, Yi, Zhou, Yue, Anker, John, Hao, Guo‐Xiang, Zhao, Wei

    Published in Clinical pharmacology and therapeutics (01-04-2024)
    “…The application of machine learning (ML) has shown promising results in precision medicine due to its exceptional performance in dealing with complex…”
    Get full text
    Journal Article
  2. 2

    Prognostic value of infarct-related-lead Tpeak–Tend/QT ratio in patients with ST-segment elevation myocardial infarction by Wu, Yue-e, Ma, Lan, Hu, Ze-ping

    Published in Heart and vessels (01-04-2022)
    “…Tpeak–Tend/QT ratio (Tp–e/QT) in patients with ST-segment elevation myocardial infarction (STEMI) is reportedly associated with major adverse cardiac events…”
    Get full text
    Journal Article
  3. 3

    Population pharmacokinetics and dose optimization of levofloxacin in elderly patients with pneumonia by He, Yun‐Ying, Sun, Jing, Wu, YueE, Wang, Yong‐Bin, Anker, John, Hao, Guo‐Xiang, Sun, De‐Qing, Zhao, Wei

    Published in British journal of clinical pharmacology (01-05-2024)
    “…Aims Levofloxacin is a quinolone antibiotic with a broad antibacterial spectrum. It is frequently used in elderly patients with pneumonia. The pharmacokinetic…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Population pharmacokinetics and dosing optimization of mezlocillin in neonates and young infants by Zhou, Jing, Jiang, Li, Zhang, Zhi Ling, Wang, Zhao Rui, Zhang, Yan Xiu, Lin, Xu, Tang, Bo Hao, Yao, Bu Fan, Guo, Zi Xuan, Yang, Jing Jing, Van Den Anker, John, Wu, Yue E, Zhao, Wei

    Published in Journal of antimicrobial chemotherapy (28-07-2022)
    “…Abstract Objectives Mezlocillin is used in the treatment of neonatal infectious diseases. However, due to the absence of population pharmacokinetic studies in…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Clinical utility of a model‐based amoxicillin dosage regimen in neonates with early‐onset sepsis by Kou, Chen, Li, Di‐Fei, Tang, Bo‐Hao, Dong, Lei, Yao, Bu‐Fan, Anker, John, You, Dian‐Ping, Wu, YueE, Zhao, Wei

    Published in British journal of clinical pharmacology (01-11-2022)
    “…Early‐onset sepsis (EOS) is one of the most significant causes of morbidity and mortality in neonates. Currently, amoxicillin is empirically used to treat…”
    Get full text
    Journal Article
  9. 9

    Epithelial lining fluid concentrations of ceftriaxone in children with community‐acquired pneumonia by Dong, Yi‐Ning, Wang, Ya‐Kun, Li, Qian, Tang, Bo‐Hao, Anker, John, Hao, Guo‐Xiang, Zheng, Yi, Tian, Li‐Yuan, You, Dian‐Ping, Wu, YueE, Zhao, Wei

    Published in British journal of clinical pharmacology (01-04-2023)
    “…Ceftriaxone is widely used in children with community‐acquired pneumonia. Currently, there are no available data regarding epithelial lining fluid (ELF)…”
    Get full text
    Journal Article
  10. 10

    Relationship Between Linezolid Exposure and the Typical Clinical Laboratory Safety and Bacterial Clearance in Chinese Pediatric Patients by Huo, Ben-Nian, Wu, Yue-E., Shu, Ling, Zhang, Ruo-Qi, Xiao, Jian-Wen, Li, Qian-Bo, Zhao, Wei, Jia, Yun-Tao, Song, Lin

    Published in Frontiers in pharmacology (01-08-2022)
    “…Objectives: There have been limited studies concerning the safety and efficacy of linezolid (LZD) in children. This study aimed to evaluate the association…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Optimal dose of cefotaxime in neonates with early-onset sepsis: A developmental pharmacokinetic model-based evaluation by Shang, Zhen-Hai, Wu, Yue-E, Lv, Dong-Mei, Zhang, Wei, Liu, Wen-Qiang, van den Anker, John, Xu, Yan, Zhao, Wei

    Published in Frontiers in pharmacology (07-09-2022)
    “…Objective: The perspective of real-world study is especially relevant to newborns, enabling dosage regimen optimization and regulatory approval of medications…”
    Get full text
    Journal Article
  13. 13

    Clinical utiliy of a model‐based piperacillin dose in neonates with early‐onset sepsis by Wu, YueE, Hou, Shan‐Shan, Fang, Zeng‐Yu, Tang, Bo‐Hao, Yao, Bu‐Fan, Dong, Yi‐Ning, Li, Xue, Shi, Hai‐Yan, Zheng, Yi, Hao, Guo‐Xiang, Huang, Xin, Van Den Anker, John, Yu, Yong‐Hui, Zhao, Wei

    Published in British journal of clinical pharmacology (01-03-2022)
    “…Aims Early‐onset sepsis (EOS) is a common disease in neonates with a high morbidity and mortality rate. Piperacillin/tazobactam has been used extensively and…”
    Get full text
    Journal Article
  14. 14

    Population Pharmacokinetics and Dosing Optimization of Amoxicillin in Chinese Infants by Wu, YueE, Wang, Ya‐Kun, Tang, Bo‐Hao, Dong, Lei, Li, Xue, Zhang, Wei, Li, Di‐Fei, Tian, Li‐Yuan, den Anker, John, You, Dian‐Ping, Zhao, Wei

    Published in Journal of clinical pharmacology (01-04-2021)
    “…Amoxicillin is used to treat various bacterial infections (eg, pneumonia, sepsis, meningitis) in infants. Despite its frequent use, there is a lack of…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Systematic review of efficacy, safety and pharmacokinetics of intravenous and intraventricular vancomycin for central nervous system infections by Liu, Shu-Ping, Xiao, Jing, Liu, Ya-Li, Wu, Yue-E, Qi, Hui, Wang, Zhuang-Zhuang, Shen, A-Dong, Liu, Gang, Zhao, Wei

    Published in Frontiers in pharmacology (18-11-2022)
    “…The decision of vancomycin dosage for central nervous system (CNS) infections is still a challenge because its bactericidal nature in cerebrospinal fluid (CSF)…”
    Get full text
    Journal Article
  17. 17

    Developmental Population Pharmacokinetics and Dosing Optimization of Cefepime in Neonates and Young Infants by Zhao, Yang, Yao, Bu-Fan, Kou, Chen, Xu, Hai-Yan, Tang, Bo-Hao, Wu, Yue-E, Hao, Guo-Xiang, Zhang, Xin-Ping, Zhao, Wei

    Published in Frontiers in pharmacology (04-02-2020)
    “…Cefepime is used to treat severe infections in neonates. Pharmacokinetic data have only been evaluated among preterm neonates and population pharmacokinetic…”
    Get full text
    Journal Article
  18. 18

    Carbapenem-Resistant Enterobacteriaceae Bloodstream Infection Treated Successfully With High-Dose Meropenem in a Preterm Neonate by Wu, Yue-E, Xu, Hai-Yan, Shi, Hai-Yan, van den Anker, John, Chen, Xiao-Yu, Zhao, Wei

    Published in Frontiers in pharmacology (11-09-2020)
    “…Carbapenem-resistant enterobacteriaceae (CRE) bloodstream infections have been rapidly spreading worldwide with a high mortality and pose a challenge to…”
    Get full text
    Journal Article
  19. 19

    Meropenem for children with severe pneumonia: Protocol for a randomized controlled trial by Tian, Xue, Dong, Lei, Jiang, Ting-Ting, Tang, Bo-Hao, Wang, Ze-Ming, Wu, Yue-E, You, Dian-Ping, Bi, Jing, Qian, Su-Yun, Qi, Hui, Shen, A-Dong

    Published in Frontiers in pharmacology (17-11-2022)
    “…Background: Pneumonia, caused by infection or other factors, seriously endangers the health of children. Meropenem is an effective broad-spectrum antibiotic…”
    Get full text
    Journal Article
  20. 20

    Developmental Pharmacogenetics of CYP2D6 in Chinese Children: Loratadine as a Substrate Drug by Li, Qian, Wu, Yue-E, Wang, Kai, Shi, Hai-Yan, Zhou, Yue, Zheng, Yi, Hao, Guo-Xiang, Yang, Yi-Lei, Su, Le-Qun, Wang, Wen-Qi, Yang, Xin-Mei, Zhao, Wei

    Published in Frontiers in pharmacology (06-07-2021)
    “…Objective: The elucidation of CYP2D6 developmental pharmacogenetics in children has improved, however, these findings have been largely limited to studies of…”
    Get full text
    Journal Article